161 related articles for article (PubMed ID: 30642841)
1. Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.
Amara CS; Ambati CR; Vantaku V; Badrajee Piyarathna DW; Donepudi SR; Ravi SS; Arnold JM; Putluri V; Chatta G; Guru KA; Badr H; Terris MK; Bollag RJ; Sreekumar A; Apolo AB; Putluri N
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):770-781. PubMed ID: 30642841
[TBL] [Abstract][Full Text] [Related]
2. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
3. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Vantaku V; Donepudi SR; Piyarathna DWB; Amara CS; Ambati CR; Tang W; Putluri V; Chandrashekar DS; Varambally S; Terris MK; Davies K; Ambs S; Bollag R; Apolo AB; Sreekumar A; Putluri N
Cancer; 2019 Mar; 125(6):921-932. PubMed ID: 30602056
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Vantaku V; Dong J; Ambati CR; Perera D; Donepudi SR; Amara CS; Putluri V; Ravi SS; Robertson MJ; Piyarathna DWB; Villanueva M; von Rundstedt FC; Karanam B; Ballester LY; Terris MK; Bollag RJ; Lerner SP; Apolo AB; Villanueva H; Lee M; Sikora AG; Lotan Y; Sreekumar A; Coarfa C; Putluri N
Clin Cancer Res; 2019 Jun; 25(12):3689-3701. PubMed ID: 30846479
[TBL] [Abstract][Full Text] [Related]
5. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
Luo X; Yu H; Song Y; Sun T
J Cell Physiol; 2019 Aug; 234(8):13021-13031. PubMed ID: 30556899
[TBL] [Abstract][Full Text] [Related]
6. Determinants of the urinary and serum metabolome in children from six European populations.
Lau CE; Siskos AP; Maitre L; Robinson O; Athersuch TJ; Want EJ; Urquiza J; Casas M; Vafeiadi M; Roumeliotaki T; McEachan RRC; Azad R; Haug LS; Meltzer HM; Andrusaityte S; Petraviciene I; Grazuleviciene R; Thomsen C; Wright J; Slama R; Chatzi L; Vrijheid M; Keun HC; Coen M
BMC Med; 2018 Nov; 16(1):202. PubMed ID: 30404627
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
[TBL] [Abstract][Full Text] [Related]
8. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
9. Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer.
Liu X; Jiang T; Li W; Li X; Zhao C; Shi J; Zhao S; Jia Y; Qiao M; Zhang L; Luo J; Gao G; Zhou F; Wu F; Chen X; He Y; Ren S; Su C; Zhou C
Lung Cancer; 2018 Jan; 115():109-115. PubMed ID: 29290250
[TBL] [Abstract][Full Text] [Related]
10. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
Pamungkas AD; Park C; Lee S; Jee SH; Park YH
Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
[TBL] [Abstract][Full Text] [Related]
11. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.
Lee JS; Leem SH; Lee SY; Kim SC; Park ES; Kim SB; Kim SK; Kim YJ; Kim WJ; Chu IS
J Clin Oncol; 2010 Jun; 28(16):2660-7. PubMed ID: 20421545
[TBL] [Abstract][Full Text] [Related]
12. Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
Loras A; Suárez-Cabrera C; Martínez-Bisbal MC; Quintás G; Paramio JM; Martínez-Máñez R; Gil S; Ruiz-Cerdá JL
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31100982
[TBL] [Abstract][Full Text] [Related]
13. Tumour catabolism independent of malnutrition and inflammation in upper GI cancer patients revealed by longitudinal metabolomics.
von Renesse J; von Bechtolsheim F; Jonas S; Seifert L; Alves TC; Seifert AM; Komorek F; Tritchkova G; Menschikowski M; Bork U; Meisterfeld R; Distler M; Chavakis T; Weitz J; Funk AM; Kahlert C; Mirtschink P
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):298-309. PubMed ID: 36418015
[TBL] [Abstract][Full Text] [Related]
14. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
Song BN; Kim SK; Chu IS
Exp Mol Med; 2017 Jan; 49(1):e282. PubMed ID: 28082741
[TBL] [Abstract][Full Text] [Related]
16. Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population.
Christensen CH; Rostron B; Cosgrove C; Altekruse SF; Hartman AM; Gibson JT; Apelberg B; Inoue-Choi M; Freedman ND
JAMA Intern Med; 2018 Apr; 178(4):469-476. PubMed ID: 29459935
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Differences between Ex-Smokers and Nonsmokers: A Metabolomic Analysis.
Liang L; Feng L; Zhou L; Chu S; Zhang D; Jin H; Li J; Zhao L; Tong Z
J Healthc Eng; 2022; 2022():6480749. PubMed ID: 35469229
[TBL] [Abstract][Full Text] [Related]
19. Smoking and survival after radical cystectomy for bladder cancer.
Lee C; Kim KH; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
Urology; 2012 Dec; 80(6):1307-12. PubMed ID: 23044645
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
